A call for an industry-led initiative to critically assess machine learning for real-world drug discovery
Other text in scientific journal, 2024
No abstract available
Author
Cas Wognum
Recursion Pharmaceuticals
Valence Discovery
Jeremy R. Ash
Johnson & Johnson Innovative Medicine
Matteo Aldeghi
Bayer AG
Raquel Rodríguez-Pérez
Novartis International AG
Cheng Fang
Blueprint Medicines Corporation
Alan C. Cheng
Merck
Daniel J. Price
Nimbus Therapeutics
Djork Arné Clevert
Pfizer
Ola Engkvist
AstraZeneca AB
Chalmers, Computer Science and Engineering (Chalmers)
W. Patrick Walters
Relay Therapeutics
Nature Machine Intelligence
25225839 (eISSN)
Vol. 6 10 1120-1121Subject Categories (SSIF 2011)
Computer Science
DOI
10.1038/s42256-024-00911-w